Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8733539 | Critical Reviews in Oncology/Hematology | 2018 | 13 Pages |
Abstract
Given the revolution in cancer therapy in recent years, the efficient allocation of existing resources is essential for healthcare systems to meet the evolving needs of populations and remain sustainable in the long term. The application of high quality information that stems from scientific evidence and economic modeling can help considerably to make the healthcare system sustainable over time mainly due to a higher number of therapeutic indications or more countries giving regulatory approval for the use of new and expensive cancer drugs.
Keywords
ESMOB-Raf proto-oncogene, serine/threonine kinasecytotoxic T-lymphocyte associated protein 4FDAPD-L2ASCOCTLA4PD-1RCCBRAFICERPD-L1QALYNCCNPFsHealth economicsAmerican Society of Clinical OncologyEuropean Society for Medical OncologyProgression free survivaloverall survivalNICEPharmacoeconomicsFood and Drug AdministrationLife yearquality-adjusted life yearNSCLCNon-small cell lung cancerNational Comprehensive Cancer NetworkProgrammed cell death-ligand 1Incremental cost-effectiveness ratioprogrammed cell death protein-1Renal cell carcinoma
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Cássia Rita Pereira da Veiga, Claudimar Pereira da Veiga, Ana Paula Drummond-Lage,